期刊
CURRENT DRUG TARGETS
卷 22, 期 1, 页码 105-111出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389450121999201013152931
关键词
Aspirin; acetyl salicylic acid; anti-tumor activity; cancer; cellular mTOR pathways; inflammatory
Aspirin, known for its antipyretic, analgesic, anti-inflammatory, and anti-rheumatic activities, has also shown great potential in the field of cancer with mechanisms including inhibiting mTOR pathways, acting as a calorie-restricted mimetic, and suppressing platelet function. More direct evidence and solutions for side effects are still needed for wider application in cancer treatment.
Since its discovery more than 100 years ago, aspirin has been widely used for its antipyretic, analgesic, anti-inflammatory, and anti-rheumatic activities. In addition to these applications, it is increasingly becoming clear that the drug also has great potential in the field of cancer. Here, we briefly review the current insights on aspirin's anti-tumor effects. These are multiple and vary from inhibiting the major cellular mTOR pathways, acting as a calorie-restricted mimetic by inhibition of energy production, suppressing platelet aggregation and granule release, inhibiting the immune escape of tumor cells, to decreasing inflammatory responses. We consider these five mechanisms of action the most significant for aspirin's anti-tumor effects, whereby the anti-tumor effect may ultimately stem from its inhibition of energy metabolism, platelet function, and inflammatory response. As such, aspirin can play an important role to reduce the occurrence, proliferation, and metastasis of various types of tumors. However, most of the collected data are still based on epidemiological investigations. More direct and effective evidence is needed, and the side effects of aspirin intake need to be solved before this drug can be widely applied in cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据